All variants in the LDLR gene

Information The variants shown are described using the NM_000527.4 transcript reference sequence.

5 entries on 1 page. Showing entries 1 - 5.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Enzyme activity     

Predict-BioInf     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     
+?/+? 4 c.502G>A r.(?) p.(Asp168Asn) LDL-receptor class A4 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 1, HumVar probably damaging, 1; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 1 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, X, Z, S) ACGS likely pathogenic g.11216084G>A g.11105408G>A D147N - LDLR_001749 predicted ligand binding defect; Authors report pathogenic prediction using Alamut software; Normal levels of expression (mRNA and peptide), reduced levels LDL-binding and LDL uptake found in variant plasmid transfected CHO-ldlA7 cells, therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12} PubMed: Laurie 2004 - rs200727689 Germline - 0.00001652 ExAC, May 2015 - - - Sarah Leigh
+?/+? 4 c.502G>A r.(?) p.(Asp168Asn) LDL-receptor class A4 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 1, HumVar probably damaging, 1; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 1 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, X, Z, S) ACGS likely pathogenic g.11216084G>A g.11105408G>A D147N - LDLR_001749 predicted ligand binding defect; Normal levels of expression (mRNA and peptide), reduced levels LDL-binding and LDL uptake found in variant plasmid transfected CHO-ldlA7 cells, therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12} PubMed: Punzalan 2005 - rs200727689 Germline - 0.00001652 ExAC, May 2015 - - - Sarah Leigh
+?/+? 4 c.502G>A r.(?) p.(Asp168Asn) LDL-receptor class A4 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 1, HumVar probably damaging, 1; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 1 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, X, Z, S) ACGS likely pathogenic g.11216084G>A g.11105408G>A D147N - LDLR_001749 predicted ligand binding defect; Normal levels of expression (mRNA and peptide), reduced levels LDL-binding and LDL uptake found in variant plasmid transfected CHO-ldlA7 cells, therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12} PubMed: Day 1997 - rs200727689 Germline - 0.00001652 ExAC, May 2015 - - - Sarah Leigh
+?/+? 4 c.502G>A r.(?) p.(Asp168Asn) LDL-receptor class A4 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 1, HumVar probably damaging, 1; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 1 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, X, Z, S) ACGS likely pathogenic g.11216084G>A g.11105408G>A D147N - LDLR_001749 predicted ligand binding defect; Normal levels of expression (mRNA and peptide), reduced levels LDL-binding and LDL uptake found in variant plasmid transfected CHO-ldlA7 cells, therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12} PubMed: Lee 1998 - rs200727689 Germline - 0.00001652 ExAC, May 2015 - - - Sarah Leigh
+/. - c.502G>A r.(?) p.(Asp168Asn) - - - - pathogenic (dominant) g.11216084G>A - - - LDLR_001749 - PubMed: Roman 2020, Journal: Roman 2020 - - Germline - - - - - Johan den Dunnen
Legend   How to query